Amedeo Smart

Free Medical Literature Service

 

Amedeo

Head and Neck Cancer
  Free Subscription

Articles published in
Gastrointest Endosc
    November 2024
  1. FUJIYOSHI Y, Khalaf K, He T, Tham D, et al
    Comparison of EMR versus endoscopic submucosal dissection for Barrett's neoplasia and esophageal adenocarcinoma: a systematic review and meta-analysis.
    Gastrointest Endosc. 2024;100:817-828.
    >> Share

  2. MOHAPATRA S, Al Ghamdi SS, Charilaou P, Lopimpisuth C, et al
    Predictors for lymph node metastasis and survival of patients with T1b esophageal adenocarcinoma treated with surgery and endoscopic therapy: an analysis of the Surveillance, Epidemiology, and End Results database.
    Gastrointest Endosc. 2024;100:849-856.
    >> Share

    October 2024
  3. JUKEMA JB, Kusters CHJ, Jong MR, Fockens KN, et al
    Computer-aided diagnosis improves characterization of Barrett's neoplasia by general endoscopists (with video).
    Gastrointest Endosc. 2024;100:616-625.
    >> Share

  4. PROBST A, Kappler F, Ebigbo A, Albers D, et al
    Endoscopic submucosal dissection for early esophageal adenocarcinoma: low rates of metastases in mucosal cancers with poor differentiation.
    Gastrointest Endosc. 2024;100:626-636.
    >> Share

    September 2024
  5. BLASBERG T, Meiborg M, Richl J, Weber M, et al
    Prophylactic endoscopic vacuum therapy for stricture prevention following wide-field endoscopic submucosal dissection of superficial esophageal cancer.
    Gastrointest Endosc. 2024 Sep 10:S0016-5107(24)03437.
    >> Share

  6. XU Y, Liang W
    Circumferential range should be identified as most important risk factor for esophageal stenosis after endoscopic submucosal dissection.
    Gastrointest Endosc. 2024;100:577.
    >> Share

  7. FOCKENS KN, Jukema JB, Jong MR, Boers T, et al
    The use of a real-time computer-aided detection system for visible lesions in the Barrett's esophagus during live endoscopic procedures: a pilot study (with video).
    Gastrointest Endosc. 2024;100:527-531.
    >> Share

    August 2024
  8. SCHEMBRE D
    Freeze frame: Is spray cryotherapy the hot new thing for Barrett's dysplasia?
    Gastrointest Endosc. 2024;100:210-212.
    >> Share

  9. WANG WL, Tsai YN, Hsu MH, Lin JT, et al
    Administration of oral prednisolone to prevent esophageal stricture after balloon-type radiofrequency ablation for ultralong-segment esophageal neoplasia.
    Gastrointest Endosc. 2024;100:192-199.
    >> Share

  10. YANG D, Hasan MK, Xiao Y, Gabr M, et al
    The use of a self-assembling peptide gel for stricture prevention in the esophagus after endoscopic submucosal dissection: a U.S. multicenter prospective study (with video).
    Gastrointest Endosc. 2024;100:213-220.
    >> Share

  11. ELURI S, Cotton CC, Kaul V, McKinley M, et al
    Liquid nitrogen spray cryotherapy for eradication of dysplastic Barrett's esophagus: results from a multicenter prospective registry.
    Gastrointest Endosc. 2024;100:200-209.
    >> Share

    July 2024
  12. JIANG H, Tian B, Gao Y, Bian Y, et al
    Risk and Pathological Factors of Recurrence after Endoscopic Resection for Superficial Esophageal Squamous Cell Carcinoma: A Systematic Review and Meta-analysis.
    Gastrointest Endosc. 2024 Jul 22:S0016-5107(24)03359.
    >> Share

  13. KOSEKI M, Nishimura M, Nammour T, Nagao S, et al
    Feasibility of esophageal endoscopic submucosal dissection after radiofrequency ablation treatment in patients with Barrett's esophagus.
    Gastrointest Endosc. 2024;100:128-131.
    >> Share

    June 2024
  14. VERLOOP CA, Goos JAC, Bruno MJ, Quispel R, et al
    Diagnostic yield of endoscopic and EUS-guided biopsy techniques in subepithelial lesions of the upper GI tract: a systematic review.
    Gastrointest Endosc. 2024;99:895-911.
    >> Share

  15. SHAH T
    Top tips for endoscopic management of malignant esophageal obstruction.
    Gastrointest Endosc. 2024;99:1017-1020.
    >> Share

    April 2024
  16. POCCI M, Alfieri R, Fassan M, Realdon S, et al
    Buried esophageal adenocarcinoma after radiofrequency ablation with pagetoid spreading.
    Gastrointest Endosc. 2024;99:642-643.
    >> Share

    March 2024
  17. HABER G
    What goes around, comes around: circumferential endoscopic submucosal dissection and stricture.
    Gastrointest Endosc. 2024;99:346-348.
    >> Share

  18. XIANG AY, Wang KH, Su W, Tan T, et al
    Endoscopic resection of giant esophageal subepithelial lesions: experience from a large tertiary center.
    Gastrointest Endosc. 2024;99:358-370.
    >> Share

  19. MOTOMURA D, Bechara R
    Complete circumferential endoscopic submucosal dissection for early Barrett's neoplasia.
    Gastrointest Endosc. 2024;99:337-345.
    >> Share

    February 2024
  20. SUNAKAWA H, Yoda Y, Nonaka S, Suzuki H, et al
    Prospective multicenter trial of the cryoballoon ablation system for superficial esophageal squamous cell carcinoma on the post-endoscopic resection scar. A CRYO-SCAR study (EPOC1902).
    Gastrointest Endosc. 2024 Feb 29:S0016-5107(24)00134.
    >> Share

  21. KOGGEL LM, Reijm AN, Lantinga MA, de Jong DJ, et al
    Multisegmented esophageal fully covered self-expandable metal stent for palliation of malignant dysphagia: a prospective multicenter feasibility and safety study.
    Gastrointest Endosc. 2024 Feb 3:S0016-5107(24)00089.
    >> Share

  22. DI L, Wu X, Tuo B
    A case of rare early type 0-IIb esophageal adenoid cystic carcinoma accompanied by squamous cell carcinoma.
    Gastrointest Endosc. 2024;99:280-281.
    >> Share

    December 2023
  23. YU S, Wang Y, Zhang Q
    A special esophageal carcinoma: both dual neoplasms and concurrent 3-type mixed esophageal carcinoma diagnosed by endoscopic submucosal dissection.
    Gastrointest Endosc. 2023;98:1023-1024.
    >> Share

  24. LADD AM, Park K, Bilal M, Schlachterman A, et al
    Prophylactic stenting to decrease the incidence of esophageal strictures after extensive endoscopic submucosal dissection: the first U.S. experience.
    Gastrointest Endosc. 2023;98:1000-1003.
    >> Share

  25. LI J, Yu L, Sun H, Ye L, et al
    Endoscopic submucosal dissection for a giant fibrovascular polyp in the esophagus.
    Gastrointest Endosc. 2023;98:1024-1025.
    >> Share

    November 2023
  26. JOSEPH A, Vantanasiri K, Draganov PV, King W, et al
    ENDOSCOPIC SUBMUCOSAL DISSECTION WITH VERSUS WITHOUT TRACTION FOR PATHOLOGICALLY STAGED T1B ESOPHAGEAL CANCER: A MULTICENTER RETROSPECTIVE STUDY.
    Gastrointest Endosc. 2023 Nov 30:S0016-5107(23)03123.
    >> Share

  27. KAWAMATA N, Shimamura Y, Tanaka I, Inoue H, et al
    Enhancing Diagnosis: The role of endocytoscopy in diagnosing small esophageal squamous cell carcinoma.
    Gastrointest Endosc. 2023 Nov 23:S0016-5107(23)03099.
    >> Share

  28. LIN YX, Liu W, Yuan XL, Hu B, et al
    Endoscopic submucosal dissection for the treatment of advanced esophageal cancer subsequent to chemotherapy.
    Gastrointest Endosc. 2023 Nov 21:S0016-5107(23)03105.
    >> Share

  29. YOSHIZAKI T, Yamamoto Y, Sako T, Kitamura Y, et al
    Outcomes of endoscopic submucosal dissection for esophageal cancer with segmental absence of intestinal musculature.
    Gastrointest Endosc. 2023 Nov 10:S0016-5107(23)03043.
    >> Share

  30. BURTON SJ, Muniraj T
    Advancing surveillance protocols for dysplastic Barrett's esophagus after complete remission of intestinal metaplasia: Time to rethink biopsy strategy?
    Gastrointest Endosc. 2023;98:733-734.
    >> Share

  31. HE T, Sundararajan V, Clark NJ, Slavin J, et al
    Location and appearance of dysplastic Barrett's esophagus recurrence after endoscopic eradication therapy: no additional yield from random biopsy sampling neosquamous mucosa.
    Gastrointest Endosc. 2023;98:722-732.
    >> Share

    October 2023
  32. RODRIGUEZ DE SANTIAGO E, van Tilburg L, Deprez PH, Pioche M, et al
    Western outcomes of circumferential endoscopic submucosal dissection for early esophageal squamous cell carcinoma.
    Gastrointest Endosc. 2023 Oct 23:S0016-5107(23)02997.
    >> Share

  33. QIU XO, Jiang X, Chen YZ, Xia JS, et al
    New US capsule endoscopy for superficial and submucosal imaging of the esophagus: the first-in-human study.
    Gastrointest Endosc. 2023;98:642-652.
    >> Share

  34. GENG ZH, Zhu Y, Li QL, Fu PY, et al
    Muscular injury as an independent risk factor for esophageal stenosis after endoscopic submucosal dissection of esophageal squamous cell cancer.
    Gastrointest Endosc. 2023;98:534-542.
    >> Share

  35. OGASAWARA N, Kikuchi D, Tanaka M, Ochiai Y, et al
    Long-term outcome of cervical lymph node metastasis in superficial pharyngeal squamous cell carcinoma after endoscopic submucosal dissection.
    Gastrointest Endosc. 2023;98:524-533.
    >> Share

    September 2023
  36. TRINDADE AJ, Odze RD, Smith MS, Kaul V, et al
    Benefit of adjunctive wide-area transepithelial sampling with 3-dimensional computer-assisted analysis plus forceps biopsy based on Barrett's esophagus segment length.
    Gastrointest Endosc. 2023;98:316-325.
    >> Share

    August 2023
  37. ABE S, Kadota T, Saito Y
    Prediction of postendoscopic submucosal dissection esophageal stricture: Do we no longer need a protractor?
    Gastrointest Endosc. 2023;98:178-180.
    >> Share

  38. MIYAKE M, Ishihara R, Matsuura N, Ueda T, et al
    Predictors of stricture after non-circumferential endoscopic submucosal dissection of the esophagus and single-dose triamcinolone injection immediately after the procedure.
    Gastrointest Endosc. 2023;98:170-177.
    >> Share

  39. STEWART M, Menon A, Akbar U, Garg S, et al
    Missed opportunities to screen for Barrett's esophagus in the primary care setting of a large health system.
    Gastrointest Endosc. 2023;98:162-169.
    >> Share

  40. SINGH RR, Desai M, Bourke M, Falk G, et al
    Real-world evidence of safety and effectiveness of Barrett's endoscopic therapy.
    Gastrointest Endosc. 2023;98:155-161.
    >> Share

  41. SATO H, Hamada K, Abe M, Makino T, et al
    Application of the Valsalva maneuver to prevent adhesion and deformity after hypopharyngeal endoscopic submucosal dissection.
    Gastrointest Endosc. 2023;98:254-256.
    >> Share

    July 2023
  42. FORBES N, Elhanafi SE, Al-Haddad MA, Thosani NC, et al
    American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: summary and recommendations.
    Gastrointest Endosc. 2023 Jul 25:S0016-5107(23)00355.
    >> Share

  43. AL-HADDAD MA, Elhanafi SE, Forbes N, Thosani NC, et al
    American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: methodology and review of evidence.
    Gastrointest Endosc. 2023 Jul 25:S0016-5107(23)00371.
    >> Share

  44. LUO W, Zhang T
    The clinical outcomes of endoscopic submucosal dissection for superficial circumferential esophageal squamous cell carcinoma may be not as ideal as expected.
    Gastrointest Endosc. 2023;98:138.
    >> Share

    June 2023
  45. GAO Y, Li ZS, Wang LW
    Concerns about pooled performances of cytology for esophageal squamous cell carcinoma screening.
    Gastrointest Endosc. 2023;97:1169.
    >> Share

  46. BEYNA T
    Top tips for performing Barrett's ablation.
    Gastrointest Endosc. 2023;97:1137-1143.
    >> Share

    May 2023
  47. DONG J, Dai Z, Cao F, Zhang W, et al
    Effects of Percutaneous Endoscopic Gastrostomy in Patients with Esophageal Squamous Cell Carcinoma During Concurrent Chemoradiotherapy: a Prospective Study.
    Gastrointest Endosc. 2023 May 5:S0016-5107(23)02508.
    >> Share

  48. DONG Y, Li B, He D, Zhong Y, et al
    Mediastinal Castleman disease diagnosed by transesophageal submucosal tunneling endoscopic resection.
    Gastrointest Endosc. 2023;97:985-986.
    >> Share

    April 2023
  49. HUSSEIN M, Lines D, Gonzalez-Bueno Puyal J, Kader R, et al
    Computer-aided characterization of early cancer in Barrett's esophagus on i-scan magnification imaging: a multicenter international study.
    Gastrointest Endosc. 2023;97:646-654.
    >> Share

    March 2023
  50. CHUANG PL, Hsu WH, Wu IC
    Endoscopic submucosal dissection following definite chemoradiotherapy for advanced cervical esophageal cancer.
    Gastrointest Endosc. 2023 Mar 3:S0016-5107(23)00298.
    >> Share

  51. ABDELRAHIM M, Saiko M, Maeda N, Hossain E, et al
    Development and validation of artificial neural networks model for detection of Barrett's neoplasia: a multicenter pragmatic nonrandomized trial (with video).
    Gastrointest Endosc. 2023;97:422-434.
    >> Share

  52. NEHME F, Ross W, Coronel E
    Spinal cord compression related to an esophageal self-expandable metal stent.
    Gastrointest Endosc. 2023;97:594-595.
    >> Share

    February 2023
  53. PERISETTI A, Sharma P
    Tips for improving the identification of neoplastic visible lesions in Barrett's esophagus.
    Gastrointest Endosc. 2023;97:248-250.
    >> Share

  54. BEVERIDGE CA, Mittal C, Muthusamy VR, Rastogi A, et al
    Identification of visible lesions during surveillance endoscopy for Barrett's esophagus: a video-based survey study.
    Gastrointest Endosc. 2023;97:241-247.
    >> Share

    December 2022
  55. YUAN XL, Zeng XH, Liu W, Mou Y, et al
    Artificial intelligence for detecting and delineating the extent of superficial esophageal squamous cell carcinoma and precancerous lesions under narrow band imaging.
    Gastrointest Endosc. 2022 Dec 9:S0016-5107(22)02204.
    >> Share

  56. MCDONALD OG, Montgomery EA
    Artificial intelligence for dysplasia grading in Barrett's esophagus: hematoxylin and eosin is here to stay.
    Gastrointest Endosc. 2022;96:926-928.
    >> Share

  57. FAGHANI S, Codipilly DC, David Vogelsang, Moassefi M, et al
    Development of a deep learning model for the histologic diagnosis of dysplasia in Barrett's esophagus.
    Gastrointest Endosc. 2022;96:918-925.
    >> Share

    November 2022
  58. FREDERIKS CN, Overwater A, Alvarez Herrero L, Alkhalaf A, et al
    Comparison of focal cryoballoon ablation with 10- and 8-second doses for treatment of Barrett's esophagus-related neoplasia: results from a prospective European multicenter study (with video).
    Gastrointest Endosc. 2022;96:743-751.
    >> Share

    October 2022
  59. MINAMIDE T, Kawata N, Maeda Y, Yoshida M, et al
    Clinical outcomes of endoscopic submucosal dissection for superficial circumferential esophageal squamous cell carcinoma.
    Gastrointest Endosc. 2022 Oct 10. pii: S0016-5107(22)02035.
    >> Share

    September 2022
  60. DENG K, Jing W, Chen M
    More prognostic information may be harvested in the subgroup analysis of esophageal adenocarcinoma unrelated death.
    Gastrointest Endosc. 2022;96:566.
    >> Share

  61. FAN X, Wu Q, Li R, Chen W, et al
    Clinical benefit of tunnel endoscopic submucosal dissection for esophageal squamous cancer: a multicenter, randomized controlled trial.
    Gastrointest Endosc. 2022;96:436-444.
    >> Share

    August 2022
  62. KAMBOJ AK, Iyer PG
    Pushing the boundaries of endoscopic management of early-stage esophageal adenocarcinoma: Caution is advisable!
    Gastrointest Endosc. 2022;96:248-249.
    >> Share

  63. VAN MUNSTER SN, Pouw RE
    Solving the puzzle of optimal surveillance after endoscopic eradication therapy of Barrett's esophagus.
    Gastrointest Endosc. 2022;96:234-236.
    >> Share

  64. WONG MCS, Deng Y, Huang J, Bai Y, et al
    Performance of screening tests for esophageal squamous cell carcinoma: a systematic review and meta-analysis.
    Gastrointest Endosc. 2022;96:197-207.
    >> Share

  65. NIEUWENHUIS EA, van Munster SN, Meijer SL, Brosens LAA, et al
    Analysis of metastases rates during follow-up after endoscopic resection of early "high-risk" esophageal adenocarcinoma.
    Gastrointest Endosc. 2022;96:237-247.
    >> Share

  66. WOLFSON P, Ho KMA, Wilson A, McBain H, et al
    Endoscopic eradication therapy for Barrett's esophagus-related neoplasia: a final 10-year report from the UK National HALO Radiofrequency Ablation Registry.
    Gastrointest Endosc. 2022;96:223-233.
    >> Share

    July 2022
  67. LIU K, Aadam AA
    T1b esophageal cancer: Is it time for endoscopic submucosal dissection to enter the stage?
    Gastrointest Endosc. 2022 Jul 18. pii: S0016-5107(22)01681.
    >> Share

    June 2022
  68. CHAN MW, Pouw RE
    Risk-stratification models for Barrett's esophagus: Will we get to the perfect classifier?
    Gastrointest Endosc. 2022;95:1123-1125.
    >> Share

  69. THOTA PN, Nasibli J, Kumar P, Sanaka MR, et al
    Prediction of neoplastic progression in Barrett's esophagus using nanoscale nuclear architecture mapping: a pilot study.
    Gastrointest Endosc. 2022;95:1239-1246.
    >> Share

  70. NGUYEN TH, Thrift AP, Ketwaroo GA, Du XL, et al
    External validation of a model determining risk of neoplastic progression of Barrett's esophagus in a cohort of U.S. veterans.
    Gastrointest Endosc. 2022;95:1113-1122.
    >> Share

  71. DEMEESTER S, Smith C, Severson P, Loveitt A, et al
    Multicenter randomized controlled trial comparing forceps biopsy sampling with wide-area transepithelial sampling brush for detecting intestinal metaplasia and dysplasia during routine upper endoscopy.
    Gastrointest Endosc. 2022;95:1101-1110.
    >> Share

    April 2022
  72. YANG D, King W, Aihara H, Karasik MS, et al
    Effect of endoscopic submucosal dissection on histologic diagnosis in Barrett's esophagus visible neoplasia.
    Gastrointest Endosc. 2022;95:626-633.
    >> Share

    March 2022
  73. CODIPILLY DC, Iyer PG
    What's next for wide-area transepithelial sampling in Barrett's esophagus management?
    Gastrointest Endosc. 2022;95:419-421.
    >> Share

  74. AGARWAL S, Alshelleh M, Scott J, Dhaliwal L, et al
    Comparative outcomes of radiofrequency ablation and cryoballoon ablation in dysplastic Barrett's esophagus: a propensity score-matched cohort study.
    Gastrointest Endosc. 2022;95:422-431.
    >> Share

  75. SHAHEEN NJ, Smith MS, Odze RD
    Progression of Barrett's esophagus, crypt dysplasia, and low-grade dysplasia diagnosed by wide-area transepithelial sampling with 3-dimensional computer-assisted analysis: a retrospective analysis.
    Gastrointest Endosc. 2022;95:410-418.
    >> Share

    February 2022
  76. XU JQ, Zhang ZC, Chen WF, Xu MD, et al
    Repeated endoscopic submucosal dissection (ESD) as salvage treatment for local recurrence of esophageal squamous cell carcinoma after initial ESD.
    Gastrointest Endosc. 2022 Feb 28. pii: S0016-5107(22)00182.
    >> Share

  77. JOSEPH A, Draganov P, Maluf-Filho F, Aihara H, et al
    Outcomes for ESD of Pathologically Staged T1b Esophageal Cancer: A Multi-Center Study.
    Gastrointest Endosc. 2022 Feb 22. pii: S0016-5107(22)00123.
    >> Share

  78. HONING J, di Pietro M
    Surveillance for Barrett's esophagus: let's get the basics right.
    Gastrointest Endosc. 2022;95:246-248.
    >> Share

  79. PARASA S, Wallace MB, Srinivasan S, Sundaram S, et al
    Educational intervention to improve quality of care in Barrett's esophagus: the AQUIRE randomized controlled trial.
    Gastrointest Endosc. 2022;95:239-245.
    >> Share

  80. GUO Q, Fan X, Zhu S, Zhao X, et al
    Comparing N-acetylcysteine with sodium thiosulfate for relieving symptoms caused by Lugol's iodine chromoendoscopy: a randomized, double-blind trial.
    Gastrointest Endosc. 2022;95:249-257.
    >> Share

    January 2022
  81. CODIPILLY DC, Krishna Chandar A, Wang KK, Katzka DA, et al
    Wide-area transepithelial sampling for dysplasia detection in Barrett's esophagus: a systematic review and meta-analysis.
    Gastrointest Endosc. 2022;95:51-59.
    >> Share

  82. ADLER DG
    Esophageal papillomatosis presenting with complete esophageal obstruction and high positron emission tomography avidity.
    Gastrointest Endosc. 2022;95:187-188.
    >> Share

  83. FARHA N, Hrabe J, Sleiman J, Beard J, et al
    Clinically actionable findings on surveillance EGD in asymptomatic patients with Lynch syndrome.
    Gastrointest Endosc. 2022;95:105-114.
    >> Share

    December 2021
  84. TANAKA I, Hirasawa D, Matsuda T
    Extremely small but invasive esophageal cancer: endoscopists should not miss it.
    Gastrointest Endosc. 2021 Dec 1. pii: S0016-5107(21)01847.
    >> Share

    November 2021
  85. SATO D, Kadota T, Inaba A, Nishihara K, et al
    Long-term clinical outcome after endoscopic resection of esophageal squamous cell carcinoma invading the muscularis mucosae without lymphovascular invasion.
    Gastrointest Endosc. 2021 Nov 10. pii: S0016-5107(21)01781.
    >> Share

  86. FALK GW
    Low-grade dysplasia in Barrett's esophagus: More than meets the eye?
    Gastrointest Endosc. 2021;94:909-911.
    >> Share

  87. TSOI EH, Mahindra P, Cameron G, Williams R, et al
    Barrett's esophagus with low-grade dysplasia: high rate of upstaging at Barrett's esophagus referral units suggests progression rates may be overestimated.
    Gastrointest Endosc. 2021;94:902-908.
    >> Share

    October 2021
  88. OVERWATER A, van Munster SN, Offerhaus GJA, Seldenrijk CA, et al
    Extension of early esophageal squamous cell neoplasia into ducts and submucosal glands and the role of endoscopic ablation therapy.
    Gastrointest Endosc. 2021;94:832-842.
    >> Share

    September 2021
  89. IWAMURO M, Fujii N, Tanabe S, Okada H, et al
    Desquamative esophagitis followed by esophageal cancer in a stem cell transplant recipient.
    Gastrointest Endosc. 2021 Sep 20. pii: S0016-5107(21)01650.
    >> Share

  90. FREI NF, Bergman JJGHM, Pouw RE
    Screening for Barrett's esophagus: Ready for prime time or still hard to swallow?
    Gastrointest Endosc. 2021;94:506-508.
    >> Share

  91. IYER PG, Taylor WR, Slettedahl SW, Lansing RL, et al
    Validation of a methylated DNA marker panel for the nonendoscopic detection of Barrett's esophagus in a multisite case-control study.
    Gastrointest Endosc. 2021;94:498-505.
    >> Share

    August 2021
  92. MONTGOMERY EA, Haidry R
    Treating esophageal squamous cell carcinoma with ablation: the fear of what lies beneath.
    Gastrointest Endosc. 2021 Aug 18. pii: S0016-5107(21)01495.
    >> Share

  93. XIA R, Li H, Shi J, Liu W, et al
    Cost-effectiveness of risk-stratified endoscopic screening for esophageal cancer in high-risk areas of China: a modeling study.
    Gastrointest Endosc. 2021 Aug 18. pii: S0016-5107(21)01563.
    >> Share

  94. KAMBOJ AK, Leggett CL
    Barrett's esophagus indefinite for dysplasia carries a definite risk of neoplasia.
    Gastrointest Endosc. 2021;94:271-272.
    >> Share

  95. DUPREE A, Ehlken H, Rosch T, Luken M, et al
    Laparoscopic lymph node sampling: a new concept for patients with high-risk early esophagogastric junction cancer resected endoscopically.
    Gastrointest Endosc. 2021;94:282-290.
    >> Share

  96. EVERSON MA, Garcia-Peraza-Herrera L, Wang HP, Lee CT, et al
    A clinically interpretable convolutional neural network for the real-time prediction of early squamous cell cancer of the esophagus: comparing diagnostic performance with a panel of expert European and Asian endoscopists.
    Gastrointest Endosc. 2021;94:273-281.
    >> Share

  97. PHILLIPS R, Januszewicz W, Pilonis ND, O'Donovan M, et al
    The risk of neoplasia in patients with Barrett's esophagus indefinite for dysplasia: a multicenter cohort study.
    Gastrointest Endosc. 2021;94:263-270.
    >> Share

    July 2021
  98. YANG LS, Holt BA, Williams R, Norris R, et al
    Endoscopic features of buried Barrett's mucosa.
    Gastrointest Endosc. 2021;94:14-21.
    >> Share

    June 2021
  99. BARTEL MJ, Mousa OY, Brahmbhatt B, Coffman DL, et al
    Impact of topical budesonide on prevention of esophageal stricture after mucosal resection.
    Gastrointest Endosc. 2021;93:1276-1282.
    >> Share

  100. SOLFISBURG QS, Sami SS, Gabre J, Soroush A, et al
    Clinical significance of recurrent gastroesophageal junction intestinal metaplasia after endoscopic eradication of Barrett's esophagus.
    Gastrointest Endosc. 2021;93:1250-1257.
    >> Share

  101. ZHANG M, Zhu C, Wang Y, Kong Z, et al
    Differential diagnosis for esophageal protruded lesions using a deep convolution neural network in endoscopic images.
    Gastrointest Endosc. 2021;93:1261-1272.
    >> Share

    May 2021
  102. MWACHIRO MM, Dawsey SM
    Larger esophageal Lugol's unstained lesions need more follow-up: size as an important predictor for risk of premalignant lesions.
    Gastrointest Endosc. 2021;93:1074-1076.
    >> Share

  103. DE GROOF J, Antonelli G, Dinis-Ribeiro MJ, Bergman JJ, et al
    Meta-analyses of machine learning in endoscopy: stacking apples and oranges.
    Gastrointest Endosc. 2021;93:1016-1018.
    >> Share

  104. LIU M, Zhou R, Guo C, Xu R, et al
    Size of Lugol-unstained lesions as a predictor for risk of progression in premalignant lesions of the esophagus.
    Gastrointest Endosc. 2021;93:1065-1073.
    >> Share

    April 2021
  105. BABA ER, Uedo N, Rodrigues AL, da Costa Martins B, et al
    "KERATIN PEARLS IN MAGNIFYING ENDOSCOPY OF SUPERFICIAL ESOPHAGEAL SQUAMOUS CELL CARCINOMA".
    Gastrointest Endosc. 2021 Apr 22. pii: S0016-5107(21)01313.
    >> Share

  106. HAIDRY R
    Endoluminal resective therapy for residual esophageal neoplasia after definitive chemoradiotherapy: Who are we helping-the patient or the endoscopist?
    Gastrointest Endosc. 2021;93:899-901.
    >> Share

  107. SWEI E, Wagh MS
    Endoscopic submucosal dissection in the pharynx: Let's start at the very beginning!
    Gastrointest Endosc. 2021;93:828-830.
    >> Share

  108. SAPP AR, Wander P, Ali U, Gong Y, et al
    The tongue: an unusual site for esophageal adenocarcinoma metastasis diagnosed with EUS-guided FNA.
    Gastrointest Endosc. 2021;93:977-978.
    >> Share

  109. KAHN A, Priyan H, Dierkhising RA, Johnson ML, et al
    Outcomes of radiofrequency ablation by manual versus self-sizing circumferential balloon catheters for the treatment of dysplastic Barrett's esophagus: a multicenter comparative cohort study.
    Gastrointest Endosc. 2021;93:880-887.
    >> Share

  110. STRUYVENBERG MR, de Groof AJ, Fonolla R, van der Sommen F, et al
    Prospective development and validation of a volumetric laser endomicroscopy computer algorithm for detection of Barrett's neoplasia.
    Gastrointest Endosc. 2021;93:871-879.
    >> Share

  111. HANADA Y, Wang KK
    Safety and feasibility of same-day discharge after esophageal endoscopic submucosal dissection.
    Gastrointest Endosc. 2021;93:853-860.
    >> Share

  112. IIZUKA T, Kikuchi D, Suzuki Y, Tanaka M, et al
    Clinical relevance of endoscopic treatment for superficial pharyngeal cancer: feasibility of techniques corresponding to each location and long-term outcomes.
    Gastrointest Endosc. 2021;93:818-827.
    >> Share

    March 2021
  113. KAUL V, Diehl D, Enslin S, Infantolino A, et al
    Safety and efficacy of a novel powered endoscopic debridement tissue resection device for management of difficult colon and foregut lesions: first multicenter U.S. experience.
    Gastrointest Endosc. 2021;93:640-646.
    >> Share

    February 2021
  114. DESAI M, Hamade N, Sharma P
    Screening for Barrett's esophagus: challenges in identifying the population at risk.
    Gastrointest Endosc. 2021;93:420-421.
    >> Share

  115. CHEN Z, Ng H, Liu Y, Guo C, et al
    Endoscopic submucosal dissection of early squamous cell carcinoma of the soft palate.
    Gastrointest Endosc. 2021;93:517-518.
    >> Share

    January 2021
  116. SUBRAMANIAN SK, Bhakta D, Thosani N
    Hepatocellular carcinoma masquerading as nodular Barrett's esophagus.
    Gastrointest Endosc. 2021 Jan 22. pii: S0016-5107(21)00038.
    >> Share

  117. MOLENA D, DeMeester SR
    Response.
    Gastrointest Endosc. 2021;93:284-285.
    >> Share

  118. OTAKI F, Iyer PG
    Response.
    Gastrointest Endosc. 2021;93:283-284.
    >> Share

  119. STRUYVENBERG MR, de Groof AJ, van der Putten J, van der Sommen F, et al
    A computer-assisted algorithm for narrow-band imaging-based tissue characterization in Barrett's esophagus.
    Gastrointest Endosc. 2021;93:89-98.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016